Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Zender

Showing results (91-100 of 192) with videos related to

Pageof 20
Sort By:
Gastroenterology|March 31, 2011
The promoter of human telomerase reverse transcriptase is activated during liver regeneration and hepatocyte proliferationHüseyin Sirma, Mukesh Kumar, Jitendra K Meena, et al.
Cancer|June 25, 2009
Yes-associated protein is an independent prognostic marker in hepatocellular carcinomaMichelle Z Xu, Tzy-Jyun Yao, Nikki P Y Lee, et al.
Journal of Clinical Medicine|June 28, 2023
Diagnostic Performance of Dynamic Whole-Body Patlak [<sup>18</sup>F]FDG-PET/CT in Patients with Indeterminate Lung Lesions and Lymph NodesMatthias Weissinger, Max Atmanspacher, Werner Spengler, et al.
Cancer Research|November 30, 2022
A Pro-Regenerative Environment Triggers Premalignant to Malignant Transformation of Senescent HepatocytesAnna Wuestefeld, Viktoriia Iakovleva, Shirlyn Xue Ling Yap, et al.
Cancer Immunology, Immunotherapy : CII|February 4, 2021
Platelet-expressed immune checkpoint regulator GITRL in breast cancerYanjun Zhou, Jonas S Heitmann, Kim L Clar, et al.
Nature Genetics|June 19, 2007
Tissue-specific and reversible RNA interference in transgenic miceRoss A Dickins, Katherine McJunkin, Eva Hernando, et al.
Hepatology (Baltimore, Md.)|October 27, 2005
Lack of gp130 expression results in more bacterial infection and higher mortality during chronic cholestasis in miceTorsten Wuestefeld, Christian Klein, Konrad L Streetz, et al.
Hepatology (Baltimore, Md.)|May 21, 2013
Adjuvant gemcitabine therapy improves survival in a locally induced, R0-resectable model of metastatic intrahepatic cholangiocarcinomaEngin Gürlevik, Bettina Fleischmann-Mundt, Nina Armbrecht, et al.
Journal of Medicinal Chemistry|May 25, 2023
Design and Optimization of Novel Benzimidazole- and Imidazo[4,5-<i>b</i>]pyridine-Based ATM Kinase Inhibitors with Subnanomolar ActivitiesTeodor Dimitrov, Athina Anastasia Moschopoulou, Lennart Seidel, et al.
Frontiers in Oncology|July 25, 2022
Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer ProgressionSusanne M Rittig, Martina S Lutz, Kim L Clar, et al.
Pageof 20

Showing results (91-100 of 192) with videos related to

Sort By:
Pageof 20
Gastroenterology|March 31, 2011
The promoter of human telomerase reverse transcriptase is activated during liver regeneration and hepatocyte proliferationHüseyin Sirma, Mukesh Kumar, Jitendra K Meena, et al.
Cancer|June 25, 2009
Yes-associated protein is an independent prognostic marker in hepatocellular carcinomaMichelle Z Xu, Tzy-Jyun Yao, Nikki P Y Lee, et al.
Journal of Clinical Medicine|June 28, 2023
Diagnostic Performance of Dynamic Whole-Body Patlak [<sup>18</sup>F]FDG-PET/CT in Patients with Indeterminate Lung Lesions and Lymph NodesMatthias Weissinger, Max Atmanspacher, Werner Spengler, et al.
Cancer Research|November 30, 2022
A Pro-Regenerative Environment Triggers Premalignant to Malignant Transformation of Senescent HepatocytesAnna Wuestefeld, Viktoriia Iakovleva, Shirlyn Xue Ling Yap, et al.
Cancer Immunology, Immunotherapy : CII|February 4, 2021
Platelet-expressed immune checkpoint regulator GITRL in breast cancerYanjun Zhou, Jonas S Heitmann, Kim L Clar, et al.
Nature Genetics|June 19, 2007
Tissue-specific and reversible RNA interference in transgenic miceRoss A Dickins, Katherine McJunkin, Eva Hernando, et al.
Hepatology (Baltimore, Md.)|October 27, 2005
Lack of gp130 expression results in more bacterial infection and higher mortality during chronic cholestasis in miceTorsten Wuestefeld, Christian Klein, Konrad L Streetz, et al.
Hepatology (Baltimore, Md.)|May 21, 2013
Adjuvant gemcitabine therapy improves survival in a locally induced, R0-resectable model of metastatic intrahepatic cholangiocarcinomaEngin Gürlevik, Bettina Fleischmann-Mundt, Nina Armbrecht, et al.
Journal of Medicinal Chemistry|May 25, 2023
Design and Optimization of Novel Benzimidazole- and Imidazo[4,5-<i>b</i>]pyridine-Based ATM Kinase Inhibitors with Subnanomolar ActivitiesTeodor Dimitrov, Athina Anastasia Moschopoulou, Lennart Seidel, et al.
Frontiers in Oncology|July 25, 2022
Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer ProgressionSusanne M Rittig, Martina S Lutz, Kim L Clar, et al.
Pageof 20